STAAD, Switzerland--(BUSINESS WIRE)--Biosynth, a supplier of critical raw materials and services for diagnostics, vaccines, and pharmaceuticals, is pleased to announce the next step in its custom ...

Peptides have emerged as indispensable tools in modern drug discovery, playing a central role in areas such as oncology, metabolic disorders, targeted delivery, and protein–protein interaction ...

Sigma-Aldrich is a leading Life Science and High Technology company. Its biochemical and organic chemical products and kits are used in scientific and genomic research, biotechnology, pharmaceutical ...

Market Growing for Custom-Made Peptides July 1, 2006 July 1, 2006 (Vol. 26, No. 13) Expansion Attributed to Increased Use in Drug and Vaccine Development Continued growth and a changing landscape ...

Ampersand Capital Partners has recapitalized New England Peptide, a provider of high-quality custom peptides and antibodies to the global life sciences market. No financial terms were disclosed.

Customers can get in touch with Scientific Support with details of the antibody they wish to block. They can email or call Abcam, or select the “Question about a product” dropdown on the inquiries ...

Ampersand Capital Partners has acquired Peptides International and merged it with portfolio company New England Peptide. No financial terms were disclosed. Based in Louisville, Kentucky, Peptides ...

Biosynth, a supplier of critical raw materials and services for diagnostics, vaccines, and pharmaceuticals, is pleased to announce the next step in its custom peptide revolution. Automated Custom ...